LeMaitre Vascular
LMAT
179 hedge funds and large institutions have $879M invested in LeMaitre Vascular in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 71 increasing their positions, 57 reducing their positions, and 23 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 57
2.24% more ownership
Funds ownership: 85.62% → 87.86% (+2.2%)
1% more capital invested
Capital invested by funds: $872M → $879M (+$6.92M)
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
2% less funds holding
Funds holding: 183 → 179 (-4)
42% less call options, than puts
Call options by funds: $277K | Put options by funds: $478K
Top Buyers
| 1 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
+$20.6M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$10.1M |
| 3 |
Morgan Stanley
New York
|
+$4.43M |
| 4 |
CVA
Ceredex Value Advisors
Orlando,
Florida
|
+$4.17M |
| 5 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
+$3.91M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$10M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.54M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$4.97M |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.95M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.82M |
LMAT Hedge Fund Activity: Q2 2022 in Review
179 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q2 2022, worth a combined $879M — up 0.79% from $872M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of LMAT and 22 opened new positions — a net loss of 1 holder — while 57 trimmed existing stakes and 71 added.
The largest buyer was Cramer Rosenthal McGlynn, opening a new position worth an estimated $20.6M. The largest seller was Millennium Management, exiting entirely with an estimated $10M sold.
- 179 institutional investors held LeMaitre Vascular (LMAT) as of Q2 2022, down from 183 in Q1 2022.
- Funds reported $879M of LeMaitre Vascular stock for Q2 2022, up 0.79% quarter-over-quarter.
- 22 funds opened new LeMaitre Vascular positions in Q2 2022 and 23 closed out, a net change of -1 holder.
- The largest LeMaitre Vascular buyer in Q2 2022 was Cramer Rosenthal McGlynn, an estimated $20.6M added.
- The largest LeMaitre Vascular seller in Q2 2022 was Millennium Management, an estimated $10M sold.
Based on aggregated 13F filings for Q2 2022.